Efficacy of morning and evening dosing of amlodipine/valsartan combination in hypertensive patients uncontrolled by 5 mg of amlodipine

Blood Pressure Monitoring

Volumn 16, Issue 2, 2011, Pages 80-86

  Asmar, Roland ^a   Gosse, Philippe ^b   Queré, Stéphane ^c   Achouba, Assya ^c  

^a Foundation Medical Research Institutes   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c NOVARTIS PHARMA K K   (Japan)

Author keywords

ambulatory blood pressure measurement; amlodipine; blood pressure; chronotherapy; circadian rhythm; combination therapy; hypertension; valsartan

Indexed keywords

AMLODIPINE; AMLODIPINE PLUS VALSARTAN;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; DIASTOLIC BLOOD PRESSURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; ESSENTIAL HYPERTENSION; EVENING DOSAGE; FEMALE; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DRUG CHRONOTHERAPY; DRUG COMBINATIONS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TETRAZOLES;

EID: 79954633858     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBP.0b013e328344c6db     Document Type: Article

References (22)

1. Lemmer B. The importance of circadian rhythms on drug response in hypertension and coronary heart disease: from mice and man. Pharmacol Ther 2006; 111:629-651. (Pubitemid 44160520)
2. Pickering TG. Morning hypertension. J Clin Hypertens (Greenwich) 2007; 9:224-228.
3. Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure. Adv Drug Deliv Rev 2007; 59:923-939. (Pubitemid 47531897)
4. Kitahara Y, Saito F, Akao M, Fujita H, Takahashi A, Taguchi H, et al. Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypertensive patients. J Cardiovasc Pharmacol 2004; 43:68-73. (Pubitemid 38032066)
5. Morgan TO, Anderson A. Different drug classes have variable effects on blood pressure depending on the time of day. Am J Hypertens 2003; 16:46-50. (Pubitemid 36078590)
6. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. Am J Hypertens 2008; 21:948-954.
7. Hermida RC, Calvo C, Ayala DE, Fernandez JR, Covelo M, Mojon A, Lopez JE. Treatment of non-dipper hypertension with bedtime administration of valsartan. J Hypertens 2005; 23:1913-1922. (Pubitemid 41830432)
8. Hermida RC, Ayala DE, Chayan L, Mojon A, Fernandez JR. Administration time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol Int 2009; 26:61-79.
9. Hermida RC, Ayala DE, Fernandez JR, Calvo C. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 2007; 50:715-722. (Pubitemid 47442736)
10. Hermida RC, Ayala DE, Fernandez JR, Calvo C. Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension 2008; 51:69-76. (Pubitemid 350307106)
11. Philipp T, Glazer RD, Zhao Y, Pospiech R. Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension study. Curr Med Res Opin 2009; 25: 187-193.
12. Weycker D, Keskinaslan A, Levy DG, Edelsberg J, Kartashov A, Oster G. Effectiveness of add-on therapy with amlodipine in hypertensive patients receiving valsartan. Blood Press 2008; 17 (Suppl 2):5-12.
13. Sinkiewicz W, Glazer RD, Kavoliuniene A, Miglinas M, Prak H,Wernsing M, Yen J. Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on valsartan monotherapy. Curr Med Res Opin 2009; 25:315-324.
14. Flack JM, Calhoun DA, Satlin L, Barbier M, Hilkert R, Brunel P. Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study. J Hum Hypertens 2009; 23:479-489.
15. Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, et al. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Clin Ther 2007; 29:279-289. (Pubitemid 46661857)
16. Chu CS, Lee KT, Chen SH, Lu YH, Lin TH, Voon WC, et al. Morning versus evening administration of a calcium channel blocker in combination therapy for essential hypertension by ambulatory blood pressure monitoring analysis. Int Heart J 2005; 46:433-442.
17. Nold G, Strobel G, Lemmer B. Morning versus evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients. Blood Press Monit 1998; 3:17-25. (Pubitemid 28181625)
18. Qiu YG, Chen JZ, Zhu JH, Yao XY. Differential effects of morning or evening dosing of amlodipine on circadian blood pressure and heart rate. Cardiovasc Drugs Ther 2003; 17:335-341.
19. Hermida RC, Ayala DE, Calvo C. Optimal timing for antihypertensive dosing: focus on valsartan. Ther Clin Risk Manag 2007; 3:119-131. (Pubitemid 46671828)
20. Hansson L, Hedner T, Dahlof B. Prospective randomized open blinded endpoint (PROBE) study: a novel design for intervention trials. Prospective Randomized Open Blinded End-Point. Blood Press 1992; 1:113-119.
21. 2007 Guidelines for the Management of Arterial Hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology. J Hypertens 2007; 25:1105-1187.
22. Schrader J, Salvetti A, Calvo C, Akpinar E, Keeling L,Weisskopf M, Brunel P. The combination of amlodipine/valsartan 5/160mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg. Int J Clin Pract 2009; 63:217-225.